New paradigms in type 2 immunity
- PMID: 22837519
- PMCID: PMC4078898
- DOI: 10.1126/science.1221064
New paradigms in type 2 immunity
Abstract
Nearly half of the world's population harbors helminth infections or suffers from allergic disorders. A common feature of this population is the so-called "type 2 immune response," which confers protection against helminths, but also promotes pathologic responses associated with allergic inflammation. However, the mechanisms that initiate and control type 2 responses remain enigmatic. Recent advances have revealed a role for the innate immune system in orchestrating type 2 responses against a bewildering array of stimuli, from nanometer-sized allergens to 20-meter-long helminth parasites. Here, we review these advances and suggest that the human immune system has evolved multiple mechanisms of sensing such stimuli, from recognition of molecular patterns via innate immune receptors to detecting metabolic changes and tissue damage caused by these stimuli.
Figures
Similar articles
-
New paradigms in basophil development, regulation and function.Immunol Cell Biol. 2010 Mar-Apr;88(3):275-84. doi: 10.1038/icb.2010.1. Epub 2010 Feb 2. Immunol Cell Biol. 2010. PMID: 20125116 Review.
-
Regulation of type 2 immunity by basophils.Adv Exp Med Biol. 2013;785:37-41. doi: 10.1007/978-1-4614-6217-0_4. Adv Exp Med Biol. 2013. PMID: 23456835 Review.
-
Innate immunity in allergic disease.Immunol Rev. 2011 Jul;242(1):106-27. doi: 10.1111/j.1600-065X.2011.01025.x. Immunol Rev. 2011. PMID: 21682741 Review.
-
What Can Parasites Tell Us About the Pathogenesis and Treatment of Asthma and Allergic Diseases.Front Immunol. 2020 Sep 11;11:2106. doi: 10.3389/fimmu.2020.02106. eCollection 2020. Front Immunol. 2020. PMID: 33013887 Free PMC article. Review.
-
Chronic helminth infections induce immunomodulation: consequences and mechanisms.Immunobiology. 2007;212(6):475-90. doi: 10.1016/j.imbio.2007.03.009. Epub 2007 Apr 20. Immunobiology. 2007. PMID: 17544832 Review.
Cited by
-
Interleukin-33-activated basophils promote asthma by regulating Th2 cell entry into lung tissue.J Exp Med. 2024 Dec 2;221(12):e20240103. doi: 10.1084/jem.20240103. Epub 2024 Sep 19. J Exp Med. 2024. PMID: 39297875
-
Th1 polarization in Bordetella pertussis vaccine responses is maintained through a positive feedback loop.bioRxiv [Preprint]. 2024 Aug 7:2024.08.05.606623. doi: 10.1101/2024.08.05.606623. bioRxiv. 2024. PMID: 39149302 Free PMC article. Preprint.
-
Mitochondria protective and anti-apoptotic effects of peripheral benzodiazepine receptor and its ligands on the treatment of asthma in vitro and vivo.J Inflamm (Lond). 2024 Apr 19;21(1):11. doi: 10.1186/s12950-024-00383-0. J Inflamm (Lond). 2024. PMID: 38641850 Free PMC article.
-
Single-cell molecular signature of pathogenic T helper subsets in type 2-associated disorders in humans.JCI Insight. 2024 Apr 8;9(7):e177720. doi: 10.1172/jci.insight.177720. JCI Insight. 2024. PMID: 38587077 Free PMC article.
-
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.Am J Clin Dermatol. 2024 Mar;25(2):195-212. doi: 10.1007/s40257-023-00832-1. Epub 2023 Dec 29. Am J Clin Dermatol. 2024. PMID: 38157140 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- U19 AI090023/AI/NIAID NIH HHS/United States
- R37DK057665/DK/NIDDK NIH HHS/United States
- AI061570/AI/NIAID NIH HHS/United States
- U19AI057266/AI/NIAID NIH HHS/United States
- AI087990/AI/NIAID NIH HHS/United States
- R37 DK057665/DK/NIDDK NIH HHS/United States
- AI083480/AI/NIAID NIH HHS/United States
- R21 AI087990/AI/NIAID NIH HHS/United States
- AI095608/AI/NIAID NIH HHS/United States
- U01 AI095608/AI/NIAID NIH HHS/United States
- R01 AI061570/AI/NIAID NIH HHS/United States
- R01 AI074878/AI/NIAID NIH HHS/United States
- R37 AI048638/AI/NIAID NIH HHS/United States
- HHSN266200700006C/AI/NIAID NIH HHS/United States
- R38 AI140299/AI/NIAID NIH HHS/United States
- R01 AI095466/AI/NIAID NIH HHS/United States
- U19AI090023/AI/NIAID NIH HHS/United States
- U19 AI057266/AI/NIAID NIH HHS/United States
- N01 AI050025/AI/NIAID NIH HHS/United States
- AI074878/AI/NIAID NIH HHS/United States
- U54AI057157/AI/NIAID NIH HHS/United States
- R37AI48638/AI/NIAID NIH HHS/United States
- R21 AI083480/AI/NIAID NIH HHS/United States
- AI095466/AI/NIAID NIH HHS/United States
- U54 AI057157/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical